GSK names Emma Walmsley as CEO designate

Tuesday 20 September 2016
Country

United Kingdom

GlaxoSmithKline Plc has named Emma Walmsley, currently head of the company’s consumer healthcare division, as the successor to Andrew Witty, the chief executive officer. Mr Witty will be retiring on 31 March 2017.